Endothelial dysfunction has been reported in polyendocrine metabolic ovarian syndrome (PMOS) and is associated with obesity. We hypothesised that circulating biomarkers of endothelial dysfunction would not differ between non-obese women with PMOS and age- and BMI-matched controls in the absence of major between-group d...
Manjula Nandakumar, Sana Waris, T. Sathyapalan et al.· International Journal of Mol...· 0 citations
BACKGROUND AND AIMS
Heart failure with preserved ejection fraction (HFpEF) with obesity remains a therapeutic challenge with limited options. Glucagon-like peptide-1 (GLP-1) receptor agonists and dual incretin agonists may improve health status, functional capacity, and metabolic parameters. We evaluated the efficacy a...
A. Alaraibi, Fatema Naser Shakeeb, Tasneem A. Alqatta et al.· NMCD. Nutrition Metabolism a...· 0 citations
Closed-loop insulin delivery, or the artificial pancreas, has evolved from an ambitious engineering concept into one of the most consequential advances in diabetes technology. By integrating continuous glucose monitoring, insulin pumps, and control algorithms into a single feedback system, these platforms aim to shift...
R. E. Al-Dhaleai, Mustafa Tariq Khan, Zaid Chilmeran et al.· Biosensors· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.